HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes (Q34546548)

2 August 2017

HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes (English)

1 reference

2 August 2017

0 references

FinnDiane Study Group

8

1 reference

2 August 2017

K Hietala

1

1 reference

2 August 2017

J Wadén

2

1 reference

2 August 2017

C Forsblom

3

1 reference

2 August 2017

V Harjutsalo

4

1 reference

2 August 2017

J Kytö

5

1 reference

2 August 2017

P Summanen

6

1 reference

2 August 2017

P-H Groop

7

1 reference

2 August 2017

13 January 2013

1 reference

2 August 2017

1 reference

2 August 2017

56

1 reference

2 August 2017

4

1 reference

2 August 2017

737-745

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-012-2816-6

2 August 2017

0 references

cites work

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Age at onset and the risk of proliferative retinopathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Heritability of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Implementation of guidelines for the prevention of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Diabetic nephropathy is associated with low-grade inflammation in Type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Competing risks regression for clustered data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Intermittent high glucose enhances ICAM-1, VCAM-1 and E-selectin expression in human umbilical vein endothelial cells in culture: the distinct role of protein kinase C and mitochondrial superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Mechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Does the long-term clinical course of type I diabetes mellitus differ in patients with prepubertal and pubertal onset? Results of the Berlin Retinopathy Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Effectiveness of screening and monitoring tests for diabetic retinopathy--a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-012-2816-6

Prognosis of Proliferative Retinopathy in Juvenile Diabetics

21 January 2018

1 reference

12 December 2020

Competing risk analysis using R: an easy guide for clinicians

1 reference

12 December 2020

Intermittent high glucose enhances cell growth and collagen synthesis in cultured human tubulointerstitial cells

1 reference

12 December 2020

Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.

1 reference

12 December 2020

The effect of glucose variability on the risk of microvascular complications in type 1 diabetes

1 reference

12 December 2020

A comparison of childhood and adult type I diabetes mellitus

1 reference

12 December 2020

Best use of the recommended IFCC reference method, material and values in HbA1C analyses

1 reference

12 December 2020

1 reference

12 December 2020

Continuous insulin infusion therapy and retinopathy in patients with type I diabetes

1 reference

12 December 2020

10.1007/S00125-012-2816-6

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference